GNMX
Barclays’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-135
| Closed | – | – | 4107 |
|
|
2019
Q4 | $0 | Sell |
135
-17
| -11% | – | ﹤0.01% | 4475 |
|
|
2019
Q3 | $0 | Buy |
152
+83
| +120% | – | ﹤0.01% | 4620 |
|
|
2019
Q2 | $0 | Hold |
69
| – | – | ﹤0.01% | 4588 |
|
|
2019
Q1 | $0 | Hold |
69
| – | – | ﹤0.01% | 4518 |
|
|
2018
Q4 | $0 | Hold |
69
| – | – | ﹤0.01% | 4609 |
|
|
2018
Q3 | $0 | Hold |
69
| – | – | ﹤0.01% | 4606 |
|
|
2018
Q2 | $0 | Sell |
69
-1
| -1% | – | ﹤0.01% | 4517 |
|
|
2018
Q1 | $0 | Sell |
70
-99
| -59% | – | ﹤0.01% | 4503 |
|
|
2017
Q4 | $0 | Hold |
169
| – | – | ﹤0.01% | 4274 |
|
|
2017
Q3 | $0 | Sell |
169
-26,094
| -99% | – | ﹤0.01% | 4222 |
|
|
2017
Q2 | $35K | Buy |
26,263
+25,953
| +8,372% | +$34.6K | ﹤0.01% | 3120 |
|
|
2017
Q1 | $0 | Buy |
310
+227
| +273% | – | ﹤0.01% | 4231 |
|
|
2016
Q4 | $0 | Sell |
83
-88
| -51% | – | ﹤0.01% | 4090 |
|
|
2016
Q3 | $1K | Buy |
+171
| New | +$1K | ﹤0.01% | 3856 |
|
|
2015
Q4 | – | Sell |
-88
| Closed | -$1K | – | 3982 |
|
|
2015
Q3 | $1K | Sell |
88
-234
| -73% | -$2.66K | ﹤0.01% | 3840 |
|
|
2015
Q2 | $2K | Buy |
+322
| New | +$2K | ﹤0.01% | 3956 |
|
|
2014
Q3 | – | Sell |
-700
| Closed | -$5K | – | 4497 |
|
|
2014
Q2 | $5K | Buy |
+700
| New | +$5K | ﹤0.01% | 3911 |
|